标题
Biomarkers for the early diagnosis of hepatocellular carcinoma
作者
关键词
-
出版物
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 21, Issue 37, Pages 10573
出版商
Baishideng Publishing Group Inc.
发表日期
2015-09-29
DOI
10.3748/wjg.v21.i37.10573
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Multicenter analysis of soluble Axl reveals diagnostic value for very early stage hepatocellular carcinoma
- (2015) Patrick Reichl et al. INTERNATIONAL JOURNAL OF CANCER
- Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion
- (2015) Nicolas Poté et al. JOURNAL OF HEPATOLOGY
- Diagnosis Accuracy of Serum Glypican-3 in Patients with Hepatocellular Carcinoma: A Systematic Review with Meta-analysis
- (2014) Xiaobo Jia et al. ARCHIVES OF MEDICAL RESEARCH
- Axl receptor tyrosine kinase expression in breast cancer
- (2014) Timothy M D'Alfonso et al. JOURNAL OF CLINICAL PATHOLOGY
- Diagnostic and prognostic role of SCCA-IgM serum levels in hepatocellular carcinoma (HCC)
- (2014) Caterina Pozzan et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Serum soluble urokinase plasminogen activator receptor as a screening test for the early diagnosis of hepatocellular carcinoma
- (2014) Athina Chounta et al. LIVER INTERNATIONAL
- Diagnostic value of alpha-fetoprotein-L3 and Golgi protein 73 in hepatocellular carcinomas with low AFP levels
- (2014) Wan-Ju Xu et al. TUMOR BIOLOGY
- Comparison osteopontin vs AFP for the diagnosis of HCC: A meta-analysis
- (2014) Hao-Guang Wan et al. Clinics and Research in Hepatology and Gastroenterology
- The expression of Axl receptor tyrosine kinase influences the tumour phenotype and clinical outcome of patients with malignant pleural mesothelioma
- (2013) D J Pinato et al. BRITISH JOURNAL OF CANCER
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- First-in-Man Phase I Study of GC33, a Novel Recombinant Humanized Antibody Against Glypican-3, in Patients with Advanced Hepatocellular Carcinoma
- (2013) A. X. Zhu et al. CLINICAL CANCER RESEARCH
- AXL Is a Key Regulator of Inherent and Chemotherapy-Induced Invasion and Predicts a Poor Clinical Outcome in Early-Stage Colon Cancer
- (2013) P. D. Dunne et al. CLINICAL CANCER RESEARCH
- A blood-based three-gene signature for the non-invasive detection of early human hepatocellular carcinoma
- (2013) Ming Shi et al. EUROPEAN JOURNAL OF CANCER
- MicroRNA-200a and -200b Mediated Hepatocellular Carcinoma Cell Migration Through the Epithelial to Mesenchymal Transition Markers
- (2012) Chin-Sheng Hung et al. ANNALS OF SURGICAL ONCOLOGY
- Annexin A2 is a discriminative serological candidate in early hepatocellular carcinoma
- (2012) Yulin Sun et al. CARCINOGENESIS
- Phase I Trial of a Glypican-3-Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
- (2012) Y. Sawada et al. CLINICAL CANCER RESEARCH
- An Epithelial-Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance
- (2012) L. A. Byers et al. CLINICAL CANCER RESEARCH
- Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study
- (2012) Angela M Liu et al. BMJ Open
- HAb18G/CD147 promotes cell motility by regulating annexin II-activated RhoA and Rac1 signaling pathways in hepatocellular carcinoma cells
- (2011) Pu Zhao et al. HEPATOLOGY
- Identification of osteopontin as a novel marker for early hepatocellular carcinoma
- (2011) Sufen Shang et al. HEPATOLOGY
- Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation
- (2011) Zhong-Bo Han et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma
- (2011) Jian Zhou et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): An emerging field for advanced technologies
- (2011) Jens U. Marquardt et al. JOURNAL OF HEPATOLOGY
- Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma
- (2011) Yoshito Tomimaru et al. JOURNAL OF HEPATOLOGY
- Highly sensitive lens culinaris agglutinin-reactive α-fetoprotein is useful for early detection of hepatocellular carcinoma in patients with chronic liver disease
- (2011) Akio Ido ONCOLOGY REPORTS
- The Progression of Liver Fibrosis Is Related with Overexpression of the miR-199 and 200 Families
- (2011) Yoshiki Murakami et al. PLoS One
- Prognostic value of intact and cleaved forms of the urokinase plasminogen activator receptor in a retrospective study of 518 colorectal cancer patients
- (2010) Anne Fog Lomholt et al. ACTA ONCOLOGICA
- Hepatocellular Carcinoma: Novel Molecular Approaches for Diagnosis, Prognosis, and Therapy
- (2010) Augusto Villanueva et al. Annual Review of Medicine
- Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma
- (2010) Xianzhou Song et al. CANCER
- AXL Is an Essential Factor and Therapeutic Target for Metastatic Ovarian Cancer
- (2010) E. B. Rankin et al. CANCER RESEARCH
- Micromarkers: miRNAs in cancer diagnosis and prognosis
- (2010) Manuela Ferracin et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma
- (2010) Yilei Mao et al. GUT
- Diagnostic and Treatment Algorithm of the Japanese Society of Hepatology: A Consensus-Based Practice Guideline
- (2010) Namiki Izumi ONCOLOGY
- Automated immunoassay system for AFP–L3% using on-chip electrokinetic reaction and separation by affinity electrophoresis
- (2009) Chiaki Kagebayashi et al. ANALYTICAL BIOCHEMISTRY
- α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma
- (2009) Jorge A. Marrero et al. GASTROENTEROLOGY
- Des-γ-Carboxy Prothrombin and α-Fetoprotein as Biomarkers for the Early Detection of Hepatocellular Carcinoma
- (2009) Anna S. Lok et al. GASTROENTEROLOGY
- Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
- (2009) Sean F. Altekruse et al. JOURNAL OF CLINICAL ONCOLOGY
- Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers
- (2009) Pisit Tangkijvanich et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- GP73, a resident Golgi glycoprotein, is sensibility and specificity for hepatocellular carcinoma of diagnosis in a hepatitis B-endemic Asian population
- (2009) Jin-song Hu et al. MEDICAL ONCOLOGY
- Early Hepatocellular Carcinoma: Pathology, Imaging, and Therapy
- (2008) Tadatoshi Takayama et al. ANNALS OF SURGICAL ONCOLOGY
- Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: New aspects and applications
- (2008) Evi N. Debruyne et al. CLINICA CHIMICA ACTA
- Cleaved Forms of the Urokinase Plasminogen Activator Receptor in Plasma Have Diagnostic Potential and Predict Postoperative Survival in Patients with Ovarian Cancer
- (2008) E. Henic et al. CLINICAL CANCER RESEARCH
- Utility of Lens culinaris Agglutinin-Reactive Fraction of α-Fetoprotein and Des-Gamma-Carboxy Prothrombin, Alone or in Combination, as Biomarkers for Hepatocellular Carcinoma
- (2008) Richard K. Sterling et al. Clinical Gastroenterology and Hepatology
- Annexin II/Annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer
- (2008) Yusuke Shiozawa et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Utility and limitations of glypican-3 expression for the diagnosis of hepatocellular carcinoma at both ends of the differentiation spectrum
- (2008) Nafis Shafizadeh et al. MODERN PATHOLOGY
- Squamous cell carcinoma antigen in human liver carcinogenesis
- (2007) M Guido et al. JOURNAL OF CLINICAL PATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started